Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Summary

RATIONALE: Monoclonal antibodies can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This clinical trial is studying the side effects and best dose of a monoclonal antibody in treating patients with stage IV melanoma.

Timeline

Start

2008-04-08

Primary completion

2010-02-15

Completion

2012-05-22

Drugs

Indications